论文部分内容阅读
目的分析B超及X线双重定位进行体外碎石后口服坦索罗辛治疗输尿管结石的疗效。方法选择2012年9月至2013年10月输尿管结石患者120例,采取随机原则将患者均分为对照组与治疗组。对照组在B超及X线双重定位后采用体外碎石治疗,嘱患者每日饮水量≥2 L/d,余无特殊要求;治疗组在体外碎石治疗后,予口服坦索罗辛治疗。并观察患者排石情况(观察期≤2周)。结果对照组排石52例(86.7%),治疗组排石56例(93.3%)。两组排石率比较差异无统计学意义(P>0.05)。治疗组平均排石时间为(4.6±2.7)d,短于对照组[(5.6±4.0)d],差异有统计学意义(P<0.05)。结论在体外冲击波碎石后口服坦索罗辛治疗输尿管结石安全有效,能缩短排石时间,较单独使用有极好的临床效果。
Objective To analyze the curative effect of oral tamsulosin in the treatment of ureteral calculi after B-mode ultrasonography and X-ray double positioning in vitro. Methods 120 patients with ureteral calculi from September 2012 to October 2013 were randomly divided into control group and treatment group. The patients in the control group were treated with extracorporeal gravel after double-locating B-mode ultrasound and X-ray. The patient’s daily drinking water volume was ≥2 L / d, with no special requirements. After treatment with lithotripsy, the patients in the treatment group were treated with tamsulosin . And observe the patient row of stone (observation period ≤ 2 weeks). Results In the control group, 52 patients (86.7%) were discharged with row stones and 56 patients (93.3%) in the treatment group. There was no significant difference between the two groups (P> 0.05). The mean time of stone removal in the treatment group was (4.6 ± 2.7) days, which was shorter than that in the control group [(5.6 ± 4.0) days], the difference was statistically significant (P <0.05). Conclusions The oral tamsulosin treatment of ureteral calculi after ESWL is safe and effective, which can shorten the time of stone discharging and has an excellent clinical effect compared with single use.